Trends over time in the incidence and use of hormonal therapy in endometrial cancer: a population-based study in the Netherlands.

Willem Jan van WeeldenReini BretveldAndrea RomanoStephan van ErpSam EngelsRoy I LalisangJohanna PijnenborgMaaike van der Aa

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2021)

The use of primary hormonal therapy in endometrioid type endometrial cancer increased over time in patients aged ≤40 years and among elderly patients. The observed trends in the current use of hormonal therapy support the need to study the effect of hormonal treatment in elderly patients and as adjuvant treatment in advanced stage endometrial cancer.

Keyphrases

endometrial cancer
polycystic ovary syndrome
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
stem cells
risk factors
peritoneal dialysis
metabolic syndrome
replacement therapy
patient reported outcomes
smoking cessation